Association of Expression of PD-L1 with the Tumor Immune Microenvironment in Small Cell Lung Cancer

被引：0
|
作者：
Yu, Hui [1 ]
Badzio, Andrzej [2 ]
Boyle, Theresa A. [1 ]
Chan, Dan [1 ]
Rivard, Christopher J. [1 ]
Lu, Xian [3 ]
Kowalewski, Ashley A. [1 ]
Ellison, Kim [1 ]
Hirsch, Fred R. [1 ]
机构：
[1] Univ Colorado, Div Med Oncol, Aurora, CO USA
[2] Med Univ Gdansk, Dept Oncol & Radiotherapy, Gdansk, Poland
[3] Univ Colorado, Sch Publ Hlth, Biostat & Informat, Denver, CO USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
PD-L1; TIICs; SCLC;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ORAL25.06
引用
收藏
页码：S222 / S223
页数：2
相关论文
共 50 条
  • [41] Significance of PD-L1 and Tumor Microenvironment in Laryngeal Squamous Cell Cancer
    Tudor, Filip
    Marijic, Blazen
    Babarovic, Emina
    Hadzisejdic, Ita
    [J]. CANCERS, 2024, 16 (15)
  • [42] Meta-Analysis of Circulating Tumor Cell PD-L1 Expression and the Association with Clinical Outcomes in Non-Small Cell Lung Cancer
    Acheampong, Emmanuel
    Allsopp, Rebecca C.
    Page, Karen
    Wadsley, Marc K.
    Beasley, Aaron B.
    Coombes, R. Charles
    Shaw, Jacqui A.
    Gray, Elin S.
    [J]. CLINICAL CHEMISTRY, 2024, 70 (01) : 234 - 249
  • [43] Elucidation of the relationships of MET protein expression and gene copy number status with PD-L1 expression and the immune microenvironment in non-small cell lung cancer
    Yoshimura, Katsuhiro
    Inoue, Yusuke
    Tsuchiya, Kazuo
    Karayama, Masato
    Yamada, Hidetaka
    Iwashita, Yuji
    Kawase, Akikazu
    Tanahashi, Masayuki
    Ogawa, Hiroshi
    Inui, Naoki
    Funai, Kazuhito
    Shinmura, Kazuya
    Niwa, Hiroshi
    Suda, Takafumi
    Sugimura, Haruhiko
    [J]. LUNG CANCER, 2020, 141 : 21 - 31
  • [44] Differential expression of PD-L1 and PD-L2 is associated with the tumor microenvironment of TILs and M2 TAMs and tumor differentiation in non-small cell lung cancer
    Sumitomo, Ryota
    Huang, Cheng-Long
    Fujita, Masaaki
    Cho, Hiroyuki
    Date, Hiroshi
    [J]. ONCOLOGY REPORTS, 2022, 47 (04)
  • [45] Significance of the Expression of PD-L1/PD-1 by Tumoral and Immune Cells in Non-Small Cell Lung Cancer.
    Ortiz-Villalon, C.
    De Petris, L.
    Kis, L.
    Yoshikawa, A.
    Ngoc, H.
    Roden, A.
    Fukuoka, J.
    Montero, A.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S948 - S948
  • [46] PD-L1 and alternative immune checkpoints (AICs) in non-small cell lung cancer (NSCLC): Insights into the tumor immune microenvironment (TIME) and immunotherapy (IO) outcomes
    D'Aiello, Angelica
    Nazari, Shayan
    Jeon, Hyein
    Elliott, Andrew
    Vanderwalde, Ari M.
    Borghaei, Hossein
    Liu, Stephen V.
    Zang, Xingxing
    Halmos, Balazs
    Cheng, Haiying
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [47] PD-L1 expression in lung cancer
    Tang, Chad
    Chang, Joe Y.
    [J]. JOURNAL OF THORACIC DISEASE, 2016, 8 (11) : 3053 - 3055
  • [48] PD-L1 Expression in Lung Cancer
    Yu, Hui
    Boyle, Theresa A.
    Zhou, Caicun
    Rimm, David L.
    Hirsch, Fred R.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (07) : 964 - 975
  • [49] PD-1/PD-L1 Immune Checkpoint Blockade in Non-Small Cell Lung Cancer
    Bagley, Stephen J.
    Bauml, Joshua M.
    Langer, Corey J.
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (10) : 676 - 683
  • [50] Modifying factors of PD-L1 expression on tumor cells in advanced non-small-cell lung cancer
    Aviles-Salas, Alejandro
    Flores-Estrada, Diana
    Lara-Mejia, Luis
    Catalan, Rodrigo
    Cruz-Rico, Graciela
    Orozco-Morales, Mario
    Heredia, David
    Bolano-Guerra, Laura
    Soberanis-Pina, Pamela Denisse
    Varela-Santoyo, Edgar
    Cardona, Andres F.
    Arrieta, Oscar
    [J]. THORACIC CANCER, 2022, 13 (23) : 3362 - 3373
12345